RXRX vs VRDN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

RXRX

51.5
AI Score
VS
RXRX Wins

VRDN

45.0
AI Score

Investment Advisor Scores

RXRX

52score
Recommendation
HOLD

VRDN

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric RXRX VRDN Winner
Revenue 14.14M 4.16M RXRX
Net Income -248.51M -3.52M VRDN
Net Margin -1757.1% -84.7% VRDN
Operating Income -263.47M -6.99M VRDN
ROE -27.2% -54.7% RXRX
ROA -20.5% -39.0% RXRX
Total Assets 1.21B 9.04M RXRX
Cash 545.68M 8.38M RXRX
Current Ratio 5.03 3.07 RXRX
Free Cash Flow -187.35M -8.85M VRDN

Relative Price Performance (Last 90 Days)

RXRX 1M: -3.2% · 3M: +20.9% VRDN 1M: +6.5% · 3M: +18.4%

Current Technical Phase

RXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $3.58

VRDN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.6 · Price: $22.82

Fundamentals Snapshot

Metric RXRX VRDN
Market Cap — —
Forward P/E -4.1 -8.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.6% 2.8%
Gross Margin -7.2% -3.6%
Operating Margin -17.6% -444.6%
EPS -1.00 -3.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.